Yoshinobu Higuchi

Title: Yoshinobu Higuchi: Innovator in Pharmaceutical Composition

Introduction

Yoshinobu Higuchi is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of atopic dermatitis. With a total of 9 patents to his name, Higuchi's work has garnered attention for its innovative approaches to medical treatment.

Latest Patents

One of Higuchi's latest patents involves a pharmaceutical composition for the prevention and/or treatment of atopic dermatitis. This composition comprises an IL-31 antagonist as the active ingredient. In a non-limiting embodiment, the IL-31 antagonist is administered repeatedly in equal amounts at the same dosing interval to a subject with or potentially with atopic dermatitis. The dosage ranges from 0.1 to 1000 mg per body per day for a duration of 1 day to 12 weeks. Preferred dosing intervals include 0.1 to 1000 mg per body every 2 weeks, 4 weeks, or 8 weeks.

Career Highlights

Higuchi has worked with notable organizations, including Chugai Seiyaku Kabushiki Kaisha and the University of Pennsylvania. His experience in these institutions has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Some of his notable coworkers include Hidetomo Kitamura and Akihisa Kaneko. Their collaborative efforts have contributed to the advancement of research in the field of pharmaceuticals.

Conclusion

Yoshinobu Higuchi's contributions to pharmaceutical compositions, particularly in the treatment of atopic dermatitis, highlight his role as an influential inventor. His innovative approaches and collaborations continue to impact the medical field positively.